TRENTON, N.J., May 15, 2019 /PRNewswire/ -- BioNJ's 9th
Annual BioPartnering Conference, developed with J.P.
Morgan and Johnson & Johnson Innovation, took place
last Wednesday, May 8, at The Palace
at Somerset Park. It was a record-breaking day with 550 attendees
from 17 states and 5 countries, up from 423 attendees in 2018; 32
company presentations; over 400 partnering meetings; provocative
sessions led by industry leaders and the introduction of our
Institution and Start-up Track -- featuring 16 early stage
companies originating from institutions in New Jersey, New
York and Pennsylvania.
"We couldn't be happier with the outcome of last week's event,"
said BioNJ President and CEO Debbie
Hart. "The Conference is about growing the ecosystem and
partnering to bolster medical innovation. The energy throughout the
day as new opportunities and business endeavors were discussed was
absolutely palpable. We thank our speakers, sponsors, planning
team, judges, company and institution exhibitors and all who
attended for making this event such a success."
The event brought together biopharmaceutical executives,
investors, academic collaborators and business development
professionals for a day of 1:1 partnering meetings, plenary
sessions, exhibits and posters, networking and company
presentations.
Hart added, "We are thrilled to have developed this year's
program in concert with our friends from J.P Morgan and Johnson
& Johnson Innovation. The commitment, expertise and thought
leadership they provided from throughout their organizations were
monumental to the success of this year's conference."
Company presentation awards were given to Michele Korfin, Chief Operating Officer for
Tyme Technologies, Inc. and Michael
Nelson, JD, Chief Executive Officer for Intrommune
Therapeutics; as well as the best pitch presentation award to
John Vito
d'Antonio-Bertagnolli, Chief Executive Officer for OculoMotor
Technologies -- a spinout from New Jersey
Institute of Technology.
Presenter profiles can be found here:
- Company Presenters
- Industry Showcase Exhibitors
- Institution Alley Exhibitors
- Poster Presenters
Registration will open later this week for BioNJ's New X2
BioCruise, with NewYorkBIO, taking place on Thursday, July 18. Join us for a scenic cruise on
the New York Harbor where you'll enjoy dinner, drinks, music and
networking. Visit www.BioNJ.org for BioNJ's full calendar of
events.
About BioNJ
BioNJ is a trade association of nearly 400 Member companies
representing research-based life sciences organizations and
stakeholders dedicated to propelling a vibrant ecosystem where
Science is Supported, Companies are Created, Drugs are Developed
and Patients are Paramount. Because Patients Can't Wait®, BioNJ
supports its Members in the discovery, development and
commercialization of therapies and cures that save and improve
lives and lessen the burden of illness and disease to society by
driving capital formation, fostering entrepreneurship, advocating
for public policies that advance medical innovation, providing
access to talent and education and offering a cost-saving array of
critical commercial resources. For more information about
BioNJ, please visit www.BioNJ.org.
Contact:
Randi Bromberg
Vice
President, Communications and Marketing
O) 609-890-3185
C) 609-955-1067
RBromberg@BioNJ.org
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bionjs-biopartnering-conference-delivered-a-day-of-innovation-partnering--learning-300850905.html
SOURCE BioNJ